Omeros Corp. (OMER)
12.83
+0.34
(+2.72%)
USD |
NASDAQ |
Jan 12, 16:00
12.72
-0.11
(-0.86%)
After-Hours: 20:00
Omeros Research and Development Expense (Quarterly): 15.76M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 748.00M |
| Johnson & Johnson | 3.693B |
| Eli Lilly & Co. | 3.466B |
| Edgewise Therapeutics, Inc. | 36.96M |
| GeoVax Labs, Inc. | 5.044M |